# Sanofi > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:6f05ca0c-a52c-469e-bd04-7efad28236e7 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/sanofi | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 35 | | Claims under review | 2 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-01T04:48:06.648942+00:00 | | Last reviewed | 2026-10-01T04:48:06.648942+00:00 | ## Identity - Legal name: Sanofi - Display name: Sanofi ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Frédéric Oudéa: Chairman of the Board of Directors. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Anne-Françoise Nesmes: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Antoine Yver: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Barbara Lavernos: Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Belén Garijo: Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Carole Ferrand: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Christel Heydemann: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Christophe Babule: Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Clotilde Delbos: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Emile Voest: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Humberto De Sousa: Director representing employees. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Jean-Paul Kress: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - John Sundy: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Lise Kingo: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Rachel Duan: Independent director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Wolfgang Laux: Director representing employees. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2. - Belén Garijo: Chief Executive Officer. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - Brendan O'Callaghan: Executive Vice President, Manufacturing & Supply. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - François Roger: Executive Vice President, Finance. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - Jamie Haney: Executive Vice President, General Counsel. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - Manuela Buxo: Executive Vice President, Specialty Care. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - Natalie Bickford: Executive VP & Chief People Officer. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4. - Olivier Charmeil: Executive Vice President of General Medicines. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4. - Paul Hudson: CEO & Director. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4. - Paulo Fontoura: Executive Vice President, Head of Research & Development. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - Pierre Chancel: Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4. - Roy Papatheodorou: Executive VP & General Counsel. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4. - Thomas Grenier: Executive Vice President, General Medicines. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - Thomas Triomphe: Executive Vice President, Vaccines. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. - Véronique Jaillet: Executive Vice President, Chief People Officer, ad interim. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:leadership_role:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - CAC 40 (PX1). Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:index_membership:37. Valid from: 2026-06-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:5. ## Legal Name - Sanofi. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1. ## Entity Status - Public listing published. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1. ## Published Fact - US. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1. - Healthcare. Claim: alpha:claim:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/sanofi). - alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2: [Sanofi Board of Directors](https://www.sanofi.com/en/our-company/governance/board-of-directors). - alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3: [Sanofi Executive Committee press release 21 July 2026](https://www.sanofi.com/assets/dotcom/pressreleases/2026/2026-07-21-16-00-00-3330752en.pdf). - alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4: [Sanofi SA key executives](https://financialmodelingprep.com/stable/key-executives?symbol=SNY). - alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:5: [CAC 40](https://live.euronext.com/sites/default/files/documentation/index-composition/CAC_40_Index_Composition.pdf). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/sanofi) - [Public Markdown](https://registry.alpha.ac/companies/sanofi.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/sanofi?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/sanofi?format=jsonld) - MCP resource: `alpha://companies/sanofi` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible.